Thomas Pabst
Bern, BE 3010, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 328 publications
Clinical Impact of a Common PDCD1 Germline Variant in DLBCL Patients Treated with CAR-T Cell Therapy.
Journal: International journal of molecular sciences
Published: July 09, 2026
Clinical Impact of a Germline CD19 Variant on Treatment Outcome After CAR-T Cell Therapy in Relapsed/Refractory Mantle Cell Lymphoma.
Journal: Cancers
Published: June 03, 2026
Influence of PPM1D Mutations on Response and Survival Outcomes Following Bispecific Antibody Therapy in Relapsed and Refractory Multiple Myeloma Patients.
Journal: Biomedicines
Published: May 18, 2026
The cumulative effect of cytogenetic abnormalities on the outcomes of myeloma patients with del(17p) undergoing AHSCT in EBMT centres between 2016 and 2022.
Journal: British journal of haematology
Published: May 15, 2026
Effects of Cementitious Amendments on the Mechanical Strength and Hydraulic Conductivity of Mine Tailings for Reclamation Cover Systems.
Journal: Geotechnical and geological engineering
Published: April 28, 2026
Elevated Allele Frequency of a Common Germline LAG3 Variant Associated with Anemia, Thrombocytopenia and Peripheral Blast Percentage in Acute Myeloid Leukemia.
Journal: Cancers
Published: April 23, 2026
Prophylactic Anakinra to Prevent Neurotoxicity After CAR T-Cell Therapy in Aggressive B-Cell Lymphomas: A Single-Center Real-World Experience.
Journal: Cancers
Published: April 17, 2026
Last Updated: 09/26/2026